http://www.retirementplannings.org/stocks-2
NASDAQ Hot Stocks to watch are – GOOG, ARIA, ABAT, RVBD, IART
Google Inc. (NASDAQ: GOOG) percentage change fell -1.25%, to close at $592.64 and its overall traded volume was 2.55M shares during the last session against its average volume of 3.44M. GOOG opened the day at $595.09, it made an intraday low of $591.67 and an intraday high of $599.69. The stock has a 52-week range of $473.02-$642.96. The market capitalization of the company stands at $191.95B and it has 323.89M outstanding shares.
Google Inc. (Google) is focused on improving the ways people connect with information. The Company generates revenue primarily by delivering online advertising. The Company focuses on areas, such as search, advertising, operating systems and platforms, and enterprise. Businesses use its AdWords program to promote their products and services with targeted advertising. In addition, the third parties that comprise the Google Network use its AdSense program to deliver relevant ads that generate revenue and enhance the user experience. In February 2010, the Company acquired Aardvar and On2 Technologies, Inc. In May 2010, The Company acquired of AdMob, Inc. (AdMob). In August 2010, the Company acquired Slide, Inc. (Slide). In December 2010, the Company acquired Widevine Technologies, Inc. (Widevine). In April 2011, the Company acquired PushLife. In September 2011, the Company acquired Zagat.
Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) percentage change fell -2.27%, to close at $11.63 and its overall traded volume was 2.52M shares during the last session the stock had average daily volume of 3.49M shares. ARIA opened the day at $11.69, it made an intraday low of $11.56 and an intraday high of $11.93. The stock has a 52 week low of $3.51 and 52 week high of $13.50. The market capitalization of the company stands at $1.54B and it has 132.55M outstanding shares. ARIAD Pharmaceuticals, Inc. (ARIAD) is a biopharmaceutical company focused on the discovery and development of drugs to provide therapeutic intervention in treating human diseases at the cellular level. As of December 31, 2010, the Company’s pipeline of product candidates included three compounds, such as ridaforolimus, ponatinib and AP26113. Its lead cancer product candidate, ridaforolimus, is an internally discovered, potent inhibitor of the protein mTOR. mTOR acts as a central regulator of protein synthesis, cell prolifera tion, cell cycle progression and cell survival. Blocking mTOR creates a starvation-like effect in cancer cells by interfering with cell growth, division, metabolism and angiogenesis.
Advanced Battery Technologies, Inc. (NASDAQ: ABAT) percentage change dropped -6.81%, to close at $0.951 and its overall traded volume was 2.51M shares during the last session against its average volume of 692,130.00. ABAT opened the day at $1.02, it made an intraday low of $0.92 and an intraday high of $1.03. The 52-week range of the stock is $0.79-$4.35. ABAT’s market capitalization is $72.37M and it has 76.14M outstanding shares. Advanced Battery Technologies, Inc., (ABAT) is a holding company with one direct subsidiary, Cashtech Investment Limited. Cashtech Investment Limited is also a holding company with two subsidiaries: Harbin ZhongQiang Power-Tech Co., Ltd. (Harbin ZQPT), which manages the assets and operations of Heilongjiang ZhongQiang Power-Tech Co., Ltd. (ZQ Power-Tech), and Wuxi ZhongQiang Autocycle Co., Ltd., (Wuxi ZQ), which is engaged in the business of manufacturing and distributing electric vehicles that utilize batteries manufactured by ZQ Power-Tech. Advanced Battery Tech nologies, Inc. also owns a 49% interest in Beyond E-Tech, Inc., that distributes cellular telephones in the United States. The Company operated in two segments: Batteries and Electric vehicles. In January 2011, the Company through its subsidiary Harbin ZQPT, acquired the assets of Shenzhen Zhongqiang New Energy Science & Technology Co., Ltd. (Shenzhen Zhongqiang).
Riverbed Technology, Inc. (NASDAQ: RVBD) slid -5.03%, to close at $27.58 and its overall traded volume was 2.51M shares during the last session the stock had average daily volume of 5.08M shares. RVBD opened the day at $28.31, it made an intraday low of $27.50 and an intraday high of $28.48. The 52-week range of the stock is $18.33-$44.70. At current market price, the market capitalization of the company stands at $4.29B and it has 155.40M outstanding shares. Riverbed Technology, Inc. (Riverbed) has developed solutions to the fundamental problems associated with information technology (IT) performance across wide area networks (WANs). Riverbed’s products include solutions for branch offices, mobile workers, private data centers, private clouds and cloud computing. The Company’s products include Steelhead products and Cascade product line. The Company’s solution, the Riverbed Optimization System (RiOS), consists of hardware and software products that address the fundamental performance limita tions of distributed computing environments. During the year ended December 31, 2010, it introduced solutions for the public cloud, including a cloud-intelligent WAN optimization solution and a cloud storage accelerator targeting back-up and select archive workloads. In November 2010, the Company acquired Global Protocols LLC (Global Protocols). In October 2010, Riverbed acquired CACE Technologies, Inc. (Cace). In July 2011, it acquired Zeus Technology.
Integra LifeSciences Holdings Corp. (NASDAQ: IART) percentage change dropped -16.40%, to close at $32.06 and its overall traded volume was 2.50M shares during the last session against its average volume of 228,940.00. IART shares were trading within the range of $31.65-$36.93 while its opening price was $36.93. The 52-week range of the stock is $31.65-$52.90. The market capitalization of the company stands at $882.21M and it has 27.52M outstanding shares. Integra LifeSciences Holdings Corporation (Integra) is an integrated medical device company. The products include implants, instruments and equipment for orthopedic surgery, neurosurgery and general surgery. Integra’s orthopedic products include devices and implants for foot and ankle, hand and wrist, tendon and peripheral nerve protection and repair, wound repair and spine. Integra is a cranial neurosurgery, offering a portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related cr itical care. In the United States, Integra provides surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. The Company sells products in three market categories: Orthopedics, Neurosurgery and Instruments. In May 2011, it acquired SeaSpine, Inc. In September 2011, the Company acquired Ascension Orthopedics, Inc.
